The Effect of Low-Level Laser Stimulation on Hearing Thresholds
- Conditions
- Hearing Loss
- Interventions
- Radiation: Low-level Laser Therapy
- Registration Number
- NCT01820416
- Lead Sponsor
- University of Iowa
- Brief Summary
The purpose of this study is to determine whether low-level laser therapy can improve hearing thresholds in individuals with hearing loss. Subjects will be randomly assigned to a treatment, placebo, or control group. The treatment group will be given a three treatment of low-level laser therapy, which consists of shining low-level lasers beams onto the ear and head. The laser beams are cool to the touch, and do not cause discomfort. Each laser treatment will last approximately 4 minutes. Three treatments will be applied three times within the course of one week. Hearing tests will be administered immediately before treatment, immediately after treatment, and six weeks after treatment. Results will be analyzed to determine the effect of the laser treatment on hearing.
- Detailed Description
Low-level laser therapy has been practiced for about 20 years in Europe and is beginning to be practiced in the US. Theoretically, laser energy in the red and near infrared light spectrum is capable of penetrating 2-5 cm into tissue and can stimulate mitochondria in the cells to produce more energy (through the production of adenosine triphosphate), which in turn may help prevent or repair tissue damage. The effects of low-level laser therapy on hearing have not been well studied. It has been suggested that laser therapy might help repair damage to the cochlea and restore some degree of hearing loss. Studies of low-level laser stimulation of cochleae utilizing microscopy, PET imaging, and MRI suggest potential therapeutic benefit to hearing. While preliminary studies suggest a possible improvement in hearing thresholds, a carefully controlled study is needed to verify the results using a valid battery of audiological tests.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 35
- bilateral sensorineural hearing loss
- normal middle ear status
- pregnant or lactating
- serious mental health illness or medical/psychiatric hospitalization
- treatment with cancer chemotherapeutic agents or aminoglycoside antibiotics
- taking Aspirin, Ibuprofen, Naprosyn, Aleve
- taking any Quinine-related drugs
- taking any loop diuretics
- have a developmental disability or cognitive impairment
- history of drug abuse
- involved in litigation or claim related to hearing loss
- regularly exposed to significant occupational or recreational noise
- have a photosensitivity disorder
- have a retinal disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Low-Level Laser Therapy Low-level Laser Therapy Low-level laser applied for approximately 4 minutes to the area around the pinna, the back of the neck, and the top of the head.
- Primary Outcome Measures
Name Time Method Change in Speech Perception 7-10 days after baseline measures recorded Hearing status, as assessed by the Connected Sentence Test (CST). Difference scores (post-test - pretest) are reported. The CST approximates everyday conversation. Scoring is based on the number of correctly repeated key words. Higher numbers indicate better scores. The minimum score is 0 (0%) and the maximum is 100 (100%). When comparing test-retest scores for an individual, Cox et al. (1988) suggest that changes of 15% or more (based on 100 key words) are indicative of significant changes. We subtracted the post-test from the pre-test, so that negative difference scores indicate worse performance, and positive difference scores indicate better performance. Difference scores with an absolute value smaller than 15 are interpreted as no significant change. In addition, pre- and post-test performance was assessed for groups using t-tests on the difference scores.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Iowa
🇺🇸Iowa City, Iowa, United States